AngioDynamics (ANGO) Reports In-Line Q2 EPS, Miss on Revenues; Lowers FY18 Revenue Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.37 +2.91%
Financial Fact:
Total operating expenses: 41.46M
Today's EPS Names:
SICP, OMID, ELME, More
Financial Fact:
Total operating expenses: 41.46M
Today's EPS Names:
SICP, OMID, ELME, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.16, in-line with the analyst estimate of $0.16. Revenue for the quarter came in at $86.7 million versus the consensus estimate of $88.42 million.
GUIDANCE:
AngioDynamics sees FY2018 EPS of $0.64-$0.68, versus the consensus of $0.66. AngioDynamics sees FY2018 revenue of $345-350 million, versus the consensus of $353.33 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Raymond James Downgrades USCB Financial holdings (USCB) to Outperform
- Roth/MKM Downgrades LKQ Corp. (LKQ) to Neutral
Create E-mail Alert Related Categories
Corporate News, Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
